| Financial Year |
March 31 2023 |
| Monetary Funds |
2,015,684,734.90 |
| Held-for-trading Financial Assets |
309,580,818.10 |
| Notes Receivable |
-- |
| Accounts Receivable |
31,370,765.73 |
| Advances to Suppliers |
42,464,364.76 |
| Other Receivables |
2,358,437.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,242,139,666.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,854,490.48 |
| Other Current Assets |
-- |
| Total Current Assets |
3,648,453,278.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,300,937,462.87 |
| Under-construction Projects |
753,188,874.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
340,304,766.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
156,000.00 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
18,299,270.12 |
| Sub-Total of Non-Current Assets |
3,498,505,509.84 |
| Total Assets |
7,146,958,788.33 |
| Short-Term Loans |
325,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
183,964,326.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,131,321.57 |
| Taxes Payable |
870,897.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
171,509,050.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
955,339,259.04 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,698,463,209.49 |
| Long-term Loans |
1,748,344,983.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,863,428,179.59 |
| Total Liabilities |
3,561,891,389.08 |
| Paid-In Capital(Or Share Stock) |
407,457,506.00 |
| Capital Surplus |
2,034,120,932.71 |
| Surplus Reserve |
42,017,340.88 |
| LESS:Treasury Stock |
119,997,110.05 |
| Undistributed Profits |
1,129,564,646.11 |
| Minority Stockholder's Interest |
4,002,357.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,581,065,041.39 |
| Owner's Equity（Stockholder's Equity） |
3,585,067,399.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,146,958,788.33 |
